Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alginate vs Mg-Al Antacid for Heartburn in Pregnancy
NCT02470117Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- Jun 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of magnesium trisilicate in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Frequency of heartburn at 2 weeks. Started Jun 2015; status: completed.
02
Drugs
magnesium trisilicate
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02470117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02470117.